Objectives: Prognostication and selection of fetuses with CDH for fetal therapy relies on ultrasound (US) estimation of contralateral lung size. Our objective was to determine inter-observer variability for 3 methods of lung size measurement in fetal CDH among 8 NAFTNet* FETO centres. Methods: Twenty reviewers and one external reference (ER) from a European TOTAL trial centre assessed measurement variability retrospectively. Reviewers were asked to rate quality of 16 anonymised US clips of the fetal head and chest from isolated left CDH and obtain head circumference (HC) and lung measurements from a selected static plane. HC was calculated by (OFD+BPD) x 1.62 or by elliptical tracer. Lung size was determined by trace (T), longest diameter (L) and anterior-posterior diameter (AP) methods. Inter-observer variability was determined by interclass correlation (ICC). Bland-Altman analysis and t-test were used to compare the agreement of different methods for lung measurement between NAFTNet reviewers and ER. Significance was defined as p < 0.05. Results: Among the NAFTNet reviewers, the ICC for HC and lung-AP, -L and -T measurements were 0.99, 0.82, 0.88, and 0.93 respectively. When comparing the NAFTNet reviewers with ER, the bias (precision) were lowest for trace and highest for longest diameter method: Trace: 4.92 (29.13); AP: 14.46 (31.88) and L: 37.19 (38.19). Bias differed from zero for the longest diameter method p=0.009 (vs. trace p=0.59 and AP p=0.16). Conclusions: Among NAFTNet FETO centres, inter-observer variability was low for HC and LA measurements. Reproducibility and agreement was highest for the trace method to determine size of the contralateral lung in CDH. This information may be useful to improve standardisation of prenatal severity assessment and identification of candidates for fetal therapy in fetuses with CDH. This study was supported by grant (5R13HD059293-05) from the Eunice Kennedy Shriver NICHD.
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Congenital diaphragmatic hernia and diaphragmatic eventration: separate entities or two sides of the same coin? Results: Fourteen fetuses with eventration with 14x3 matched CDH fetuses were included. For those with eventrations, 9 were diagnosed prenatally (64%): 7 (50%) with US, and additionally 2 with MRI. Six cases (43%) were left-sided, 6 right-sided, and 2 (14%) bilateral. There was one termination of pregnancy. Baseline characteristics were comparable in the two groups. Fetal liver was detected at the 4-chamber view plane in less eventration cases than CDH (50% vs 83%, p=0.03). There was a trend towards a higher risk of hydrothorax or hydrops in fetuses with eventration (43% vs 17%, p=0.06). Perinatal death occurred in 54% of the eventration cases and 51% of the CDH ones (p=1). On regression analysis, only the severity of lung hypoplasia at US, and not eventration was an independent predictor for perinatal mortality (OR 10.5, 
